About this trial

The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, https://frog-db.fr/) in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.

Eligibility criteria

Qualifiers

A person carrying a variant of interest in a gene analyzed in a diagnostic setting by one of the laboratories within the Genetics and Cancer Group (GGC)-Unicancer network, classified as class 3, 4 or hypomorphic class 5, and selected by the national expert group for the gene concerned.

Age ≥ 18 years.

Signed written inform consent "index case"

Any relative of an index case with cancer

Disqualifiers

Minors

Persons deprived of liberty or under guardianship (including curators).

Absence of signed written inform consent

Trial design

Treatments tested in this trial

  • salivary kit

Treatment groups

11,000 Participants
are divided into 1 treatment group

Locations

62
France
Centre Hospitalier de Bastia20604, BastiaCorsica, France
Institut Curie - Saint-Cloud site92210, Saint-CloudHaut de Seine, France
Institut Curie - Paris site75005, ParisÎle-de-France Region, France
CHU Amiens - Hôpital Nord80054, Amiens France

Sponsors and collaborators

Institut Curie

Lead sponsor